Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
Authors:
- Jolien A de VeldJVJolien A de Veld
- Shari PepplinkhuizenSPShari Pepplinkhuizen
- Willeke van der StuijtWSWilleke van der Stuijt
- Anne-Floor B E QuastAQAnne-Floor B E Quast
- Louise R A Olde NordkampLNLouise R A Olde Nordkamp
- Kirsten M KooimanKKKirsten M Kooiman
- Arthur A M WildeAWArthur A M Wilde
- Lonneke SmedingLSLonneke Smeding
- Reinoud E KnopsRKReinoud E Knops
Open Access
- 28 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (7)
Abstract
After implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), a defibrillation test (DFT) is performed to ensure that the device can effectively detect and terminate the induced ventricular arrhythmia. Data on DFT efficacy at generator replacement are scarce with a limited number of patients and conflicting results. This study evaluates conversion efficacy during DFT at elective S-ICD generator replacement in a large cohort from our tertiary centre. Retrospective data of patients who underwent an S-ICD generator replacement for battery depletion with subsequent DFT between February 2015 and June 2022 were collected. Defibrillation test data were collected from both implant and replacement procedures. PRAETORIAN scores at implant were calculated. Defibrillation test was defined unsuccessful when two conversions at 65 J failed. A total of 121 patients were included. The defibrillation test was successful in 95% after the first and 98% after two consecutive tests. This was comparable with success rates at implant, despite a significant rise in shock impedance (73 ± 23 vs. 83 ± 24 Ω, P < 0.001). Both patients with an unsuccessful DFT at 65 J successfully converted with 80 J. This study shows a high DFT conversion rate at elective S-ICD generator replacement, which is comparable to conversion rates at implant, despite a rise in shock impedance. Evaluating device position before generator replacement may be recommended to optimize defibrillation success at generator replacement.Keywords
This publication has 23 references indexed in Scilit:
- Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-DefibrillatorJACC: Clinical Electrophysiology, 2018
- Determinants of Subcutaneous Implantable Cardioverter-Defibrillator EfficacyJACC: Clinical Electrophysiology, 2017
- Failed Maximal Defibrillation Threshold Testing in the Subcutaneous Implantable Cardioverter DefibrillatorCardiology, 2016
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testingEP Europace, 2015
- The learning curve associated with the introduction of the subcutaneous implantable defibrillatorEP Europace, 2015
- Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trialEuropean Heart Journal, 2015
- Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)The Lancet, 2015
- Complications associated with defibrillation threshold testing: The Canadian experienceHeart Rhythm, 2008
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular ArrhythmiaNew England Journal of Medicine, 1996